Company Filing History:
Years Active: 2020-2024
Title: Innovations of José Ignacio Casal Álvarez
Introduction
José Ignacio Casal Álvarez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, his work focuses on methods and compositions that target specific cancer markers.
Latest Patents
His latest patents include "Methods and compositions for the treatment of IL13Ra2—overexpressing cancer." This invention relates to methods and compositions for treating IL13Rα2-overexpressing cancer, wherein the treatment comprises administering a protein tyrosine phosphatase-1B (PTP1B) inhibitor. Another significant patent is titled "Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif." This disclosure relates to agents that bind specifically to human cadherin 17 (CDH17), human cadherin 5 (CDH5), human cadherin 6 (CDH6), and human cadherin 20 (CDH20). It also discusses the use of these agents in therapy, methods for diagnosis, prognosis, and stratification of cancer in subjects, along with pharmaceutical compositions comprising these agents.
Career Highlights
Throughout his career, José Ignacio has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas (CSIC). His research has contributed to advancements in cancer therapies and diagnostics.
Collaborations
He has collaborated with professionals like Rubén Álvaro Bartolomé Conde, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
José Ignacio Casal Álvarez stands out as an influential inventor in the realm of cancer treatment, with his innovative patents paving the way for future advancements in medical therapies.